ZA95968B - Interferon alpha/beta binding protein its preparation and use - Google Patents
Interferon alpha/beta binding protein its preparation and useInfo
- Publication number
- ZA95968B ZA95968B ZA95968A ZA95968A ZA95968B ZA 95968 B ZA95968 B ZA 95968B ZA 95968 A ZA95968 A ZA 95968A ZA 95968 A ZA95968 A ZA 95968A ZA 95968 B ZA95968 B ZA 95968B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- binding protein
- interferon alpha
- beta binding
- interferon
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL108584A IL108584A (en) | 1994-02-07 | 1994-02-07 | Cloning of the interferon-binding protein ALPHA / BETA |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA95968B true ZA95968B (en) | 1995-10-10 |
Family
ID=11065792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA95968A ZA95968B (en) | 1994-02-07 | 1995-02-07 | Interferon alpha/beta binding protein its preparation and use |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0676413B9 (ja) |
JP (2) | JP3670045B2 (ja) |
KR (1) | KR100382628B1 (ja) |
CN (1) | CN1286976C (ja) |
AT (1) | ATE286509T1 (ja) |
AU (1) | AU688430B2 (ja) |
CA (1) | CA2141747C (ja) |
DE (1) | DE69533905T2 (ja) |
DK (1) | DK0676413T3 (ja) |
ES (1) | ES2236696T3 (ja) |
FI (1) | FI118084B (ja) |
IL (1) | IL108584A (ja) |
NO (1) | NO318912B1 (ja) |
PT (1) | PT676413E (ja) |
RU (4) | RU2362781C2 (ja) |
UA (1) | UA46694C2 (ja) |
ZA (1) | ZA95968B (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL118096A0 (en) * | 1996-05-01 | 1996-09-12 | Yeda Res & Dev | Antibodies against interferon alpha/beta receptor |
US7087726B2 (en) * | 2001-02-22 | 2006-08-08 | Genentech, Inc. | Anti-interferon-α antibodies |
CN1405181A (zh) * | 2001-08-10 | 2003-03-26 | 中国人民解放军军事医学科学院生物工程研究所 | 血清白蛋白与干扰素的融合蛋白 |
CA2612378A1 (en) * | 2005-06-22 | 2007-01-04 | Genentech, Inc. | Methods and compositions for targeting ifnar2 |
JP5104622B2 (ja) * | 2008-07-29 | 2012-12-19 | Jnc株式会社 | 磁性粒子を用いた測定対象物質の濃度測定法 |
AU2013211059B8 (en) * | 2012-01-20 | 2017-12-21 | Centre Hospitalier Regional Universitaire De Montpellier | Targeted mutant alpha-helical bundle cytokines |
TWI776808B (zh) | 2016-04-29 | 2022-09-11 | 美商輝瑞大藥廠 | 干擾素β抗體及其用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2653445B1 (fr) * | 1989-10-20 | 1994-07-29 | Centre Nat Rech Scient | Fragment d'adnc codant pour le gene du recepteur de l'interferon alpha et procede de preparation d'une proteine correspondante. |
ATE181961T1 (de) * | 1991-04-17 | 1999-07-15 | Medisup Int Nv | Neue wasserlösliche polypeptide mit hoher affinität für alpha- und beta- interferone |
IL106591A (en) * | 1992-09-03 | 2008-03-20 | Yeda Res & Dev | Interferon alpha/beta binding protein, its preparation and pharmaceutical compositions containing it |
-
1994
- 1994-02-07 IL IL108584A patent/IL108584A/en not_active IP Right Cessation
-
1995
- 1995-01-27 AU AU11416/95A patent/AU688430B2/en not_active Expired
- 1995-02-01 UA UA95028094A patent/UA46694C2/uk unknown
- 1995-02-03 CA CA2141747A patent/CA2141747C/en not_active Expired - Lifetime
- 1995-02-06 ES ES95101560T patent/ES2236696T3/es not_active Expired - Lifetime
- 1995-02-06 RU RU2004106773/13A patent/RU2362781C2/ru active
- 1995-02-06 EP EP95101560A patent/EP0676413B9/en not_active Expired - Lifetime
- 1995-02-06 KR KR1019950002041A patent/KR100382628B1/ko not_active IP Right Cessation
- 1995-02-06 DK DK95101560T patent/DK0676413T3/da active
- 1995-02-06 RU RU95101848/13A patent/RU2232811C2/ru active
- 1995-02-06 DE DE69533905T patent/DE69533905T2/de not_active Expired - Lifetime
- 1995-02-06 NO NO19950420A patent/NO318912B1/no not_active IP Right Cessation
- 1995-02-06 RU RU2004106775/13A patent/RU2363705C2/ru active
- 1995-02-06 FI FI950516A patent/FI118084B/fi not_active IP Right Cessation
- 1995-02-06 PT PT95101560T patent/PT676413E/pt unknown
- 1995-02-06 AT AT95101560T patent/ATE286509T1/de active
- 1995-02-07 CN CNB951001949A patent/CN1286976C/zh not_active Expired - Lifetime
- 1995-02-07 ZA ZA95968A patent/ZA95968B/xx unknown
- 1995-02-07 JP JP04353995A patent/JP3670045B2/ja not_active Expired - Lifetime
-
2004
- 2004-03-05 RU RU2004106774/13A patent/RU2336279C2/ru active
-
2005
- 2005-02-09 JP JP2005033495A patent/JP2005200422A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE184052T1 (de) | Gdf-1 und uog1 proteine | |
ES8602121A1 (es) | Procedimiento para producir un vehiculo de expresion para la formacion de uroquinasa humana | |
FI951138A0 (fi) | Puuttellisia adenovirusvektoreita ja niiden käyttö geeniterapiassa | |
IE811463L (en) | Interferons | |
SE8105657L (sv) | Mikrobiell framstellning av humanfibroblastinterferon | |
DK568587A (da) | Dna fragmenter indeholdende alkalisk cellulasegen, rekombinante plasmider indeholdende disse dna fregmenter og rekombinante mikroorganismer | |
LTIP1753A (en) | Dna sequences coding for proteins, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins | |
AU2751392A (en) | Vaccines for actinobacillus pleuropneumoniae | |
ZA95968B (en) | Interferon alpha/beta binding protein its preparation and use | |
EP0749312A4 (en) | DIROFILARIA IMMITIS - Gp29 - PROTEINS, NUCLEIC ACID MOLECULES AND THEIR USE | |
GB2171703B (en) | Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re | |
AU590861B2 (en) | New human lymphotoxin (TNF-beta) polypeptides their prepartion and use | |
ATE128728T1 (de) | Interferon-gamma bindende proteine. | |
AU8957091A (en) | Immunoglobulin-binding proteins and recombinant dna molecules coding therefor | |
EP0723016A3 (en) | Leukocyte activation factor | |
ZA979390B (en) | Polypeptides comprising domains of the GAX protein which are involved in the repression of transcription and/or which interact with other proteins, corresponding nucleic acids and their uses. | |
EP1019500A4 (en) | NEW IFN RECEPTOR 1 BINDING PROTEINS, ENCODING DNA AND METHOD FOR REGULATING THE CELLULAR RESPONSE TO INTERFERON | |
IE882662L (en) | Dna sequences, recombinant dna molecules for producing¹soluble t4 proteins |